When a stock is in a phase of consolidation, it is often a good idea for investors to analyse it since there is always the chance of a strong breakout.
Last week, the Healthier Choices Management Corp (OTCMKTS:HCMC) stock had been in the middle of a tough slump. The stock had in fact tanked by as much as 20%, but over the past couple of days, the stock has been in consolidation mode. In this situation, it might be worthwhile for investors to take a look at a key announcement from the company yesterday.
Healthier Choices announced yesterday that The Health Center that is based out of Colorado will launch the sale of Q-Cups, a product for which the company owns the patent. However, that is not the only thing to point out. The Health Center is going to fill the Q-Cups with concentrates made by the NUHI brand and then make them available for purchase at its dispensaries in Colorado.
The company is going to have a soft launch of the product over the course of the coming weeks. The full-scale launch is going to take place on July 10, 2021. After the full-scale launch, The Health Center is going to distribute Q-Cups on wholesale to licensed dispensaries located all over Colorado.
Another major factor that had been responsible for the drop in the stock price had been the announcement about the closing of the company’s rights offering last week. The rights offering had been a highly publicized event from the Healthier Choices Management Corp and the successful closing of the same had led to a bit of a selloff in the stock. However, at the same time, it should be noted that it does not seem to be a factor that is going to affect the stock for long. Investors could consider adding the stock to their watch lists at this point.
The Atossa Therapeutics (NASDAQ:ATOS) stock has been one of the biggest movers in the market over the course of the past months and the rally continued in the stock on Tuesday.
Yesterday, the stock came into sharp focus among investors and managed to record gains of 51% for the week so far. More importantly, the rally took the gains recorded by the Atossa stock over the course of the past six months to as much as 680%. Considering the magnitude of the gains made by the stock this week, it might be a good idea to take a look at the major factors that were at play.
One of the more important milestones achieved by the company in recent times is that of being included in the Russell 3000 and Russell 2000 indexes. That might have been one of the factors why fund managers might have been acquiring the Atossa stock. However, that is not the only factor at play.
There is another group of investors, including those from the Reddit community, who are attempting to trigger a gamma squeeze in the Atossa stock. These traders have been picking up plenty of short-dated call options in the Atossa stock with the aim of forcing market makers to buy more of these shares.
If that happens then the price of the Atossa stock is going to go higher. While these may be some of the factors behind the latest rally, it should be noted by investors that these factors can only bring about a temporary rise in the stock price.
The long-term fate of the stock is going to be dependent on the company’s business. At this point in time, the company has two products in its pipeline. Not too long ago, Atossa had published the Phase 2 results in relation to its breast cancer medicine Endoxifen.